Announcements Trials

Browse Landscape

Phase

Phase NA 10 Phase 2/3 1

Status

Completed 6 Recruiting 4 Terminated 3 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Leukemia, Myeloid, Acute 5 Colorectal Neoplasms 5 Breast Neoplasms 5 Stomach Neoplasms 4 Rectal Neoplasms 4 Recurrence 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Hematologic Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Acute Kidney Injury 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Thymoma 1 Thymic epithelial tumor 1 Squamous NSCLC 1 Squamous Cell Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1

Interventions

Sildenafil Citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Not yet recruiting × Fatigue × Clear all

NCT06800092 2026-05-11

SPARC

The University of Texas Medical Branch, Galveston

Phase 2/3 Not yet recruiting

Fatigue, Mental Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡